For the first time in a decade, European equities have broken out of their constantly widening valuation discount range compared to the US. Historically, such breakouts have signaled the beginning of a long-term upward trend where the valuation gap narrows significantly.

The valuation gap between Airwallex ($8B) and Ramp ($32B), which have comparable revenues, demonstrates a tangible "Asia discount." Investors significantly mark down companies with a strong presence or founding nexus in Asia due to perceived geopolitical and data security risks.

According to Dan Sundheim, European markets exhibit a significant lag in pricing successful corporate turnarounds compared to the U.S. This "voting machine" is slower, as investors who have been burned by a company's historical underperformance remain skeptical long after a new strategy shows clear signs of working.

Many non-US companies are growing as fast as the Magnificent 7, offer significantly higher dividend yields (7-8x), and trade at a 30-50% valuation discount. This represents a rare cost-benefit opportunity that investors, who typically apply such analysis to every other purchase, ignore in the stock market.

After nearly two decades of poor performance, European banks have become a compelling deep value opportunity. Pilecki highlights French banks trading at just 35-60% of tangible book value, viewing new CEO appointments as a key catalyst for a potential re-rating in the long-hated sector.

According to Jato's founder, global Limited Partners (LPs) from the US, Asia, and Brazil are showing new, strong interest in European biotech investments, a significant shift from past sentiment. This change is partly driven by geopolitics, potentially creating a valuation arbitrage opportunity as European biotechs are often initially valued lower than US peers.

Europe's primary AI bull case is not in creating foundational AI but in its large base of "AI adopters." These firms, a quarter of the index, show strong earnings outperformance and trade at a significant 27% discount to US equivalents, presenting a unique investment angle.

For the first time in a decade, European equities have broken out of their long-term trend of a widening valuation discount versus the US. Historically, such breakouts signal the beginning of a sustained, multi-year period where this valuation gap narrows significantly from its current 23%.

Contrary to popular belief, when measured in constant currency, European equities have outperformed their US counterparts since the last US elections. This trend is not widely recognized by investors, setting the stage for a potential re-evaluation of the region.